Skip to main content
Hanshang Group Co.,Ltd. logo

Hanshang Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600774 ISIN · CNE000000NC5 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,570 across all filing types
Latest filing 2022-08-31 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 600774

About Hanshang Group Co.,Ltd.

https://www.whhsg.com/

Hanshang Group Co.,Ltd. is a diversified enterprise focused on commercial operations, exhibition services, and healthcare. The company manages a portfolio of large-scale department stores, shopping malls, and specialized retail outlets. Its exhibition segment provides comprehensive venue management and event organization services for international and domestic trade fairs. Hanshang Group has significantly expanded its presence in the healthcare sector through the development and distribution of pharmaceuticals, medical devices, and health-related products. By integrating traditional commercial assets with modern biomedical research and health management services, the group targets a broad consumer base and professional medical markets, emphasizing a strategic transition toward a comprehensive health-oriented business model.

Recent filings

Filing Released Lang Actions
汉商集团关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from 汉商集团股份有限公司 regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total funds used, and references the board meeting approving the repurchase plan. The document does not contain financial statements or detailed financial analysis but focuses on the company's buyback activity and compliance with regulatory disclosure requirements. The length is short (1269 characters), and the content is specific to share repurchase progress rather than a full financial report or earnings release. Therefore, it fits the category of Transaction in Own Shares (POS).
2022-08-31 Chinese
汉商集团关于参与重庆东方药业股份有限公司破产重整进展的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 汉商集团股份有限公司 regarding its participation in the bankruptcy reorganization (破产重整) of 重庆东方药业股份有限公司. It details the progress, agreements, investment amounts, and risks related to this restructuring process. The text is a formal public disclosure about a corporate restructuring investment and related agreements, not a full financial report or audit. It does not contain financial statements or detailed financial performance data. It is also not a notice of voting results, nor a management change announcement. The document is a regulatory announcement about a significant corporate event (bankruptcy reorganization investment progress). Given the content and length (3753 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-08-30 Chinese
汉商集团2022年半年度报告
Interim / Quarterly Report Classification · 98% confidence The document is titled "2022 年半年度报告" which translates to "2022 Semi-Annual Report." It covers the period from January 1, 2022 to June 30, 2022, indicating it is a report for a period shorter than a full fiscal year. The content includes detailed financial data such as revenue, profit, cash flow, assets, liabilities, and management discussion and analysis. It also contains sections on company overview, business segments, risk factors, and financial statements. The length is substantial (15,000 characters) and contains actual financial statements and substantive financial analysis. This matches the definition of an Interim / Quarterly Report (IR). It is not an announcement or a certification, but the full report itself. Therefore, the correct classification is IR with high confidence. H1 2022
2022-08-30 Chinese
汉商集团关于召开2022年半年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2022 half-year performance explanation meeting (业绩说明会) by 汉商集团股份有限公司. It references the company's 2022 half-year report already published on August 31, 2022, and invites investors to participate in an interactive online session to discuss the half-year results. The document does not contain actual financial data or detailed financial statements but serves as a notice for an upcoming investor presentation event. Given the content and length (1395 characters), it fits the category of an Investor Presentation announcement rather than the report itself or a regulatory filing. Therefore, the appropriate classification is Investor Presentation (IP).
2022-08-30 Chinese
汉商集团第十一届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from 汉商集团股份有限公司, detailing the approval of the 2022 half-year report and an investment agreement. It includes voting results and references the half-year report but does not contain the report itself or detailed financial data. The document is short (714 characters) and serves as an announcement of board decisions rather than a full interim report. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting resolutions and decisions.
2022-08-30 Chinese
汉商集团2022年上半年经营数据公告
Regulatory Filings Classification · 95% confidence The document is titled as a "2022年上半年经营数据公告" which translates to "2022 Half-Year Operating Data Announcement." It provides detailed financial data for the first half of 2022, including revenue, cost, and gross margin by business segment, product, and region. The document explicitly states that the data is unaudited and is a disclosure of main operating data for the half-year period. The length of the document is 2526 characters, which is relatively short and the content is focused on operating data rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it is a data announcement related to the half-year period. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure of operating data without full financial statements or audit information. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a report publication announcement since it contains substantive data rather than just a notice of report availability.
2022-08-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.